{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:32:26Z","timestamp":1792517546196,"version":"4.5.0"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11064-021-03274-5","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T21:02:38Z","timestamp":1614891758000},"page":"1305-1321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities"],"prefix":"10.1007","volume":"46","author":[{"given":"Tanveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-8082","authenticated-orcid":false,"given":"Rajesh Kumar","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"3274_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE Official Report: a practical clinical definition of epilepsy. Epilepsia 55:475\u2013482. https:\/\/doi.org\/10.1111\/epi.12550","journal-title":"Epilepsia"},{"key":"3274_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","volume":"51","author":"AK Ngugi","year":"2010","unstructured":"Ngugi AK, Bottomley C, Kleinschmidt I et al (2010) Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 51:883\u2013890. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02481.x","journal-title":"Epilepsia"},{"key":"3274_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","volume":"12","author":"AM Kanner","year":"2016","unstructured":"Kanner AM (2016) Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol 12:106\u2013116. https:\/\/doi.org\/10.1038\/nrneurol.2015.243","journal-title":"Nat Rev Neurol"},{"key":"3274_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1474-4422(08)70018-8","volume":"7","author":"B Hermann","year":"2008","unstructured":"Hermann B, Seidenberg M, Jones J (2008) The neurobehavioural comorbidities of epilepsy: can a natural history be developed? Lancet Neurol 7:151\u2013160. https:\/\/doi.org\/10.1016\/S1474-4422(08)70018-8","journal-title":"Lancet Neurol"},{"key":"3274_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","volume":"37","author":"KD Laxer","year":"2014","unstructured":"Laxer KD, Trinka E, Hirsch LJ et al (2014) The consequences of refractory epilepsy and its treatment. Epilepsy Behav 37:59\u201370. https:\/\/doi.org\/10.1016\/j.yebeh.2014.05.031","journal-title":"Epilepsy Behav"},{"key":"3274_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/epi.13651","volume":"58","author":"SJ Gill","year":"2017","unstructured":"Gill SJ, Lukmanji S, Fiest KM et al (2017) Depression screening tools in persons with epilepsy: a systematic review of validated tools. Epilepsia 58:695\u2013705. https:\/\/doi.org\/10.1111\/epi.13651","journal-title":"Epilepsia"},{"key":"3274_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yebeh.2018.06.007","volume":"88","author":"CR Conway","year":"2018","unstructured":"Conway CR, Udaiyar A, Schachter SC (2018) Neurostimulation for depression in epilepsy. Epilepsy Behav 88:25\u201332. https:\/\/doi.org\/10.1016\/j.yebeh.2018.06.007","journal-title":"Epilepsy Behav"},{"key":"3274_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2012.10.020","volume":"26","author":"OY Kwon","year":"2013","unstructured":"Kwon OY, Park SP (2013) Frequency of affective symptoms and their psychosocial impact in Korean people with epilepsy: a survey at two tertiary care hospitals. Epilepsy Behav 26:51\u201356. https:\/\/doi.org\/10.1016\/j.yebeh.2012.10.020","journal-title":"Epilepsy Behav"},{"key":"3274_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.yebeh.2012.01.007","volume":"24","author":"AM Kanner","year":"2012","unstructured":"Kanner AM, Schachter SC, Barry JJ et al (2012) Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 24:156\u2013168. https:\/\/doi.org\/10.1016\/j.yebeh.2012.01.007","journal-title":"Epilepsy Behav"},{"key":"3274_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1528-1167.2009.02012.x","volume":"50","author":"DC Hesdorffer","year":"2009","unstructured":"Hesdorffer DC, Kanner AM (2009) The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia 50:978\u2013986. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02012.x","journal-title":"Epilepsia"},{"issue":"6","key":"3274_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1535-7511.2010.01382.x","volume":"10","author":"DC Hesdorffer","year":"2010","unstructured":"Hesdorffer DC, Berg AT, Kanner AM (2010) An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr 10(6):137\u2013145","journal-title":"Epilepsy Curr"},{"key":"3274_CR12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/archgenpsychiatry.2009.159","volume":"66","author":"RD Gibbons","year":"2009","unstructured":"Gibbons RD, Hur K, Brown CH et al (2009) Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 66:1354\u20131360","journal-title":"Arch Gen Psychiatry"},{"key":"3274_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pds.1932","volume":"19","author":"JB Olesen","year":"2010","unstructured":"Olesen JB, Hansen PR, Erdal J et al (2010) Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 19:518\u2013524","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3274_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jama.2010.410","volume":"303","author":"E Patorno","year":"2010","unstructured":"Patorno E, Bohn RL, Wahl PM et al (2010) Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 303:1401\u20131409. https:\/\/doi.org\/10.1001\/jama.2010.410","journal-title":"JAMA"},{"key":"3274_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1741-7015-8-4","volume":"8","author":"AC VanCott","year":"2010","unstructured":"VanCott AC, Cramer JA, Copeland LA et al (2010) Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 8:4. https:\/\/doi.org\/10.1186\/1741-7015-8-4","journal-title":"BMC Med"},{"key":"3274_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ana.25623","volume":"86","author":"JW Dreier","year":"2019","unstructured":"Dreier JW, Pedersen CB, Gasse C et al (2019) Antiepileptic drugs and suicide: role of prior suicidal behavior and parental psychiatric disorder. Ann Neurol 86:951\u2013961. https:\/\/doi.org\/10.1002\/ana.25623","journal-title":"Ann Neurol"},{"key":"3274_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","volume":"62","author":"K Alper","year":"2007","unstructured":"Alper K, Schwartz KA, Kolts RL et al (2007) Seizure Incidence in psychopharmacological clinical trials: an analysis of food and drug administration (FDA) summary basis of approval reports. Biol Psychiatry 62:345\u2013354. https:\/\/doi.org\/10.1016\/j.biopsych.2006.09.023","journal-title":"Biol Psychiatry"},{"key":"3274_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-015-0701-9","volume":"15","author":"T Hill","year":"2015","unstructured":"Hill T, Coupland C, Morriss R et al (2015) Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: Cohort study using a primary care database. BMC Psychiatry 15:1\u201313. https:\/\/doi.org\/10.1186\/s12888-015-0701-9","journal-title":"BMC Psychiatry"},{"key":"3274_CR19","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.4088\/JCP.16m11377","volume":"78","author":"CS Wu","year":"2017","unstructured":"Wu CS, Liu HY, Tsai HJ et al (2017) Seizure risk associated with antidepressant treatment among patients with depressive disorders: a population-based case-crossover study. J Clin Psychiatry 78:1226\u20131232","journal-title":"J Clin Psychiatry"},{"key":"3274_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0219137","volume":"14","author":"J Christensen","year":"2019","unstructured":"Christensen J, Pedersen HS, Fenger-Gr\u00f8n M et al (2019) Selective serotonin reuptake inhibitors and risk of epilepsy after traumatic brain injury\u2014a population based cohort study. PLoS ONE 14:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0219137","journal-title":"PLoS ONE"},{"key":"3274_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.nbd.2013.11.020","volume":"63","author":"L Cardamone","year":"2014","unstructured":"Cardamone L, Salzberg MR, Koe AS et al (2014) Chronic antidepressant treatment accelerates kindling epileptogenesis in rats. Neurobiol Dis 63:194\u2013200. https:\/\/doi.org\/10.1016\/j.nbd.2013.11.020","journal-title":"Neurobiol Dis"},{"key":"3274_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/epi.14435","volume":"59","author":"C Li","year":"2018","unstructured":"Li C, Silva J, Ozturk E et al (2018) Chronic fluoxetine treatment accelerates kindling epileptogenesis in mice independently of 5-HT2A receptors. Epilepsia 59:114\u2013119. https:\/\/doi.org\/10.1111\/epi.14435","journal-title":"Epilepsia"},{"key":"3274_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eplepsyres.2019.05.001","volume":"154","author":"M Emamghoreishi","year":"2019","unstructured":"Emamghoreishi M, Shahpari M, Keshavarz M (2019) Interaction of sigma-1 receptor modulators with seizure development in pentylenetetrazole-induced kindled mice. Epilepsy Res 154:74\u201376. https:\/\/doi.org\/10.1016\/j.eplepsyres.2019.05.001","journal-title":"Epilepsy Res"},{"key":"3274_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0138178","volume":"10","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Pun RYK, Peariso K et al (2015) Olfactory bulbectomy leads to the development of epilepsy in mice. PLoS ONE 10:1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0138178","journal-title":"PLoS ONE"},{"key":"3274_CR25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nrneurol.2011.104","volume":"7","author":"C Hoppe","year":"2011","unstructured":"Hoppe C, Elger CE (2011) Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neurol 7:462\u2013472. https:\/\/doi.org\/10.1038\/nrneurol.2011.104","journal-title":"Nat Rev Neurol"},{"key":"3274_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.yebeh.2017.02.032","volume":"70","author":"R Ribot","year":"2017","unstructured":"Ribot R, Ouyang B, Kanner AM (2017) The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: is it worth investigating? Epilepsy Behav 70:5\u20139. https:\/\/doi.org\/10.1016\/j.yebeh.2017.02.032","journal-title":"Epilepsy Behav"},{"key":"3274_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010682","author":"MJ Maguire","year":"2013","unstructured":"Maguire MJ, Pulman J, Singh J et al (2013) Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010682","journal-title":"Cochrane Database Syst Rev"},{"key":"3274_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0140-6736(90)91938-7","volume":"336","author":"J Harmant","year":"1990","unstructured":"Harmant J, van Rijckevorsel-Harmant K et al (1990) Fluvoxamine: an antidepressant with low (or no) epileptogenic effect. Lancet 336:386","journal-title":"Lancet"},{"key":"3274_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1006\/ebeh.2000.0123","volume":"1","author":"J Hovorka","year":"2000","unstructured":"Hovorka J, Herman E, Nemcov\u00e1 I (2000) Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav 1:444\u2013447. https:\/\/doi.org\/10.1006\/ebeh.2000.0123","journal-title":"Epilepsy Behav"},{"key":"3274_CR30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.yebeh.2003.08.009","volume":"4","author":"KU K\u00fchn","year":"2003","unstructured":"K\u00fchn KU, Quednow BB, Thiel M et al (2003) Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4:674\u2013679. https:\/\/doi.org\/10.1016\/j.yebeh.2003.08.009","journal-title":"Epilepsy Behav"},{"key":"3274_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.yebeh.2011.07.016","volume":"22","author":"M Okazaki","year":"2011","unstructured":"Okazaki M, Adachi N, Ito M et al (2011) One-year seizure prognosis in epilepsy patients treated with antidepressants. Epilepsy Behav 22:331\u2013335. https:\/\/doi.org\/10.1016\/j.yebeh.2011.07.016","journal-title":"Epilepsy Behav"},{"key":"3274_CR32","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1212\/wnl.45.10.1926","volume":"45","author":"E Favale","year":"1995","unstructured":"Favale E, Rubino V, Mainardi P et al (1995) Anticonvulsant effect of fluoxetine in humans. Neurology 45:1926\u20131927. https:\/\/doi.org\/10.1212\/wnl.45.10.1926","journal-title":"Neurology"},{"key":"3274_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/s1059-1311(02)00315-1","volume":"12","author":"E Favale","year":"2003","unstructured":"Favale E, Audenino D, Cocito L et al (2003) The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 12:316\u2013318. https:\/\/doi.org\/10.1016\/s1059-1311(02)00315-1","journal-title":"Seizure"},{"key":"3274_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1059-1311(05)80192-X","volume":"3","author":"GL Gigli","year":"1994","unstructured":"Gigli GL, Diomedi M, Troisi A et al (1994) Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy. Seizure 3:221\u2013224. https:\/\/doi.org\/10.1016\/S1059-1311(05)80192-X","journal-title":"Seizure"},{"key":"3274_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/ebeh.2000.0050","volume":"1","author":"AM Kanner","year":"2000","unstructured":"Kanner AM, Kozak AM, Frey M (2000) The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 1:100\u2013105. https:\/\/doi.org\/10.1006\/ebeh.2000.0050","journal-title":"Epilepsy Behav"},{"key":"3274_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00002826-200405000-00009","volume":"27","author":"LM Specchio","year":"2004","unstructured":"Specchio LM, Iudice A, Specchio N et al (2004) Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 27:133\u2013136. https:\/\/doi.org\/10.1097\/00002826-200405000-00009","journal-title":"Clin Neuropharmacol"},{"key":"3274_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/phar.1549","volume":"35","author":"J McKean","year":"2015","unstructured":"McKean J, Watts H, Mokszycki R (2015) Breakthrough seizures after starting vilazodone for depression. Pharmacotherapy 35:6\u20138. https:\/\/doi.org\/10.1002\/phar.1549","journal-title":"Pharmacotherapy"},{"key":"3274_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/0141076816666805","volume":"109","author":"A Bielefeldt","year":"2016","unstructured":"Bielefeldt A, Danborg PB, G\u00f8tzsche PC (2016) Precursors to suicidality and violence on antidepressants: systematic review of trials in adult healthy volunteers. J R Soc Med 109:381\u2013392. https:\/\/doi.org\/10.1177\/0141076816666805","journal-title":"J R Soc Med"},{"key":"3274_CR39","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1046\/j.1528-1157.2002.48701.x","volume":"43","author":"EJ Hernandez","year":"2002","unstructured":"Hernandez EJ, Williams PA, Dudek FE (2002) Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 43:1337\u20131345. https:\/\/doi.org\/10.1046\/j.1528-1157.2002.48701.x","journal-title":"Epilepsia"},{"key":"3274_CR40","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1093\/brain\/awn117","volume":"131","author":"A Mazarati","year":"2008","unstructured":"Mazarati A, Siddarth P, Baldwin RA et al (2008) Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 131:2071\u20132083. https:\/\/doi.org\/10.1093\/brain\/awn117","journal-title":"Brain"},{"key":"3274_CR41","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1528-1167.2012.03436.x","volume":"53","author":"K Vermoesen","year":"2012","unstructured":"Vermoesen K, Massie A, Smolders I, Clinckers R (2012) The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy. Epilepsia 53:870\u2013878. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03436.x","journal-title":"Epilepsia"},{"key":"3274_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.14581\/jer.17005","volume":"7","author":"RK Sharma","year":"2017","unstructured":"Sharma RK, Singh T, Mishra A et al (2017) Relative safety of different antidepressants for treatment of depression in chronic epileptic animals associated with depression. J Epilepsy Res 7:25\u201332. https:\/\/doi.org\/10.14581\/jer.17005","journal-title":"J Epilepsy Res"},{"key":"3274_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4088\/jcp.v58n0101","volume":"58","author":"D Blumer","year":"1997","unstructured":"Blumer D (1997) Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin psychiatry 58:3. https:\/\/doi.org\/10.4088\/jcp.v58n0101","journal-title":"J Clin psychiatry"},{"key":"3274_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0165-0327(85)90091-6","volume":"9","author":"MM Robertson","year":"1985","unstructured":"Robertson MM, Trimble MR (1985) The treatment of depression in patients with epilepsy. A double-blind trial. J Affect Disord 9:127\u2013136. https:\/\/doi.org\/10.1016\/0165-0327(85)90091-6","journal-title":"J Affect Disord"},{"key":"3274_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.yebeh.2007.01.004","volume":"10","author":"MS Thome-Souza","year":"2007","unstructured":"Thome-Souza MS, Kuczynski E, Valente KD (2007) Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 10:417\u2013425. https:\/\/doi.org\/10.1016\/j.yebeh.2007.01.004","journal-title":"Epilepsy Behav"},{"key":"3274_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.expneurol.2014.09.004","volume":"263","author":"S Klein","year":"2015","unstructured":"Klein S, Bankstahl JP, L\u00f6scher W et al (2015) Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy. Exp Neurol 263:263\u2013271. https:\/\/doi.org\/10.1016\/j.expneurol.2014.09.004","journal-title":"Exp Neurol"},{"key":"3274_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1535-7511.2010.01382.x","volume":"10","author":"DC Hesdorffer","year":"2010","unstructured":"Hesdorffer DC, Berg AT, Kanner AM (2010) An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr 10:137\u2013145. https:\/\/doi.org\/10.1111\/j.1535-7511.2010.01382.x","journal-title":"Epilepsy Curr"},{"key":"3274_CR48","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/bph.12052","volume":"168","author":"L Cardamone","year":"2013","unstructured":"Cardamone L, Salzberg MR, O\u2019Brien TJ et al (2013) Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol 168:1531\u20131554. https:\/\/doi.org\/10.1111\/bph.12052","journal-title":"Br J Pharmacol"},{"key":"3274_CR49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1528-1167.2008.01813.x","volume":"50","author":"MS Kelley","year":"2009","unstructured":"Kelley MS, Jacobs MP, Lowenstein DH (2009) The NINDS epilepsy research benchmarks. Epilepsia 50:579\u2013582. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01813.x","journal-title":"Epilepsia"},{"key":"3274_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrneurol.2010","volume":"7","author":"A Vezzani","year":"2011","unstructured":"Vezzani A, French J, Bartfai T et al (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7:31. https:\/\/doi.org\/10.1038\/nrneurol.2010","journal-title":"Nat Rev Neurol"},{"key":"3274_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tins.2013.11.002","volume":"37","author":"N Marchi","year":"2014","unstructured":"Marchi N, Granata T, Janigro D (2014) Inflammatory pathways of seizure disorders. Trends Neurosci 37:55\u201365. https:\/\/doi.org\/10.1016\/j.tins.2013.11.002","journal-title":"Trends Neurosci"},{"key":"3274_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","volume":"53","author":"JD Rosenblat","year":"2014","unstructured":"Rosenblat JD, Cha DS, Mansur RB et al (2014) Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuro-Psychopharmacology Biol Psychiatry 53:23\u201334. https:\/\/doi.org\/10.1016\/j.pnpbp.2014.01.013","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"3274_CR53","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.seizure.2016.10.018","volume":"44","author":"CE Elger","year":"2017","unstructured":"Elger CE, Johnston SA, Hoppe C (2017) Diagnosing and treating depression in epilepsy. Seizure 44:184\u2013193. https:\/\/doi.org\/10.1016\/j.seizure.2016.10.018","journal-title":"Seizure"},{"key":"3274_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s13311-014-0271-4","volume":"11","author":"AM Kanner","year":"2014","unstructured":"Kanner AM, Mazarati A, Koepp M (2014) Biomarkers of epileptogenesis: psychiatric comorbidities (?). Neurotherapeutics 11:358\u2013372. https:\/\/doi.org\/10.1007\/s13311-014-0271-4","journal-title":"Neurotherapeutics"},{"key":"3274_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/epi.13786","volume":"58","author":"AM Mazarati","year":"2017","unstructured":"Mazarati AM, Lewis ML, Pittman QJ (2017) Neurobehavioral comorbidities of epilepsy: role of inflammation. Epilepsia 58:48\u201356. https:\/\/doi.org\/10.1111\/epi.13786","journal-title":"Epilepsia"},{"key":"3274_CR56","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","volume":"15","author":"A Vezzani","year":"2019","unstructured":"Vezzani A, Balosso S, Ravizza T (2019) Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol 15:459\u2013472. https:\/\/doi.org\/10.1038\/s41582-019-0217-x","journal-title":"Nat Rev Neurol"},{"key":"3274_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0347-z","volume":"12","author":"GM Arisi","year":"2015","unstructured":"Arisi GM, Foresti ML, Katki K et al (2015) Increased CCL2, CCL3, CCL5, and IL-1\u03b2 cytokine concentration in piriform cortex, hippocampus, and neocortex after pilocarpine-induced seizures. J Neuroinflammation 12:1\u20137. https:\/\/doi.org\/10.1186\/s12974-015-0347-z","journal-title":"J Neuroinflammation"},{"key":"3274_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neubiorev.2016.02.007","volume":"63","author":"EE de Vries","year":"2016","unstructured":"de Vries EE, van den Munckhof B, Braun KPJ et al (2016) Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci Biobehav Rev 63:177\u2013190. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.02.007","journal-title":"Neurosci Biobehav Rev"},{"key":"3274_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","volume":"29","author":"T Ravizza","year":"2008","unstructured":"Ravizza T, Gagliardi B, No\u00e9 F et al (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29:142\u2013160. https:\/\/doi.org\/10.1016\/j.nbd.2007.08.012","journal-title":"Neurobiol Dis"},{"key":"3274_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuroscience.2005.07.063","volume":"137","author":"T Ravizza","year":"2006","unstructured":"Ravizza T, Vezzani A (2006) Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 137:301\u2013308. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.07.063","journal-title":"Neuroscience"},{"key":"3274_CR61","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.55.2.250","volume":"55","author":"DC Henshall","year":"2000","unstructured":"Henshall DC, Clark RSB, Adelson PD et al (2000) Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 55:250\u2013257. https:\/\/doi.org\/10.1212\/WNL.55.2.250","journal-title":"Neurology"},{"key":"3274_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.eplepsyres.2015.09.013","volume":"119","author":"WF Peng","year":"2016","unstructured":"Peng WF, Ding J, Li X et al (2016) N-methyl-d-aspartate receptor NR2B subunit involved in depression-like behaviours in lithium chloride-pilocarpine chronic rat epilepsy model. Epilepsy Res 119:77\u201385. https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.09.013","journal-title":"Epilepsy Res"},{"key":"3274_CR63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nbd.2015.07.003","volume":"82","author":"C Roseti","year":"2015","unstructured":"Roseti C, van Vliet EA, Cifelli P et al (2015) GABAA currents are decreased by IL-1\u03b2 in epileptogenic tissue of patients with temporal lobe epilepsy: Implications for ictogenesis. Neurobiol Dis 82:311\u2013320. https:\/\/doi.org\/10.1016\/j.nbd.2015.07.003","journal-title":"Neurobiol Dis"},{"key":"3274_CR64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.eplepsyres.2008.12.006","volume":"84","author":"L Holtman","year":"2009","unstructured":"Holtman L, van Vliet EA, van Schaik R et al (2009) Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res 84:56\u201366. https:\/\/doi.org\/10.1016\/j.eplepsyres.2008.12.006","journal-title":"Epilepsy Res"},{"key":"3274_CR65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0014-4886(02)00019-5","volume":"179","author":"B Tu","year":"2003","unstructured":"Tu B, Bazan NG (2003) Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol 179:167\u2013175. https:\/\/doi.org\/10.1016\/s0014-4886(02)00019-5","journal-title":"Exp Neurol"},{"key":"3274_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/epi.12461","volume":"55","author":"A Rojas","year":"2014","unstructured":"Rojas A, Jiang J, Ganesh T et al (2014) Cyclooxygenase-2 in epilepsy. Epilepsia 55:17\u201325. https:\/\/doi.org\/10.1111\/epi.12461","journal-title":"Epilepsia"},{"key":"3274_CR67","doi-asserted-by":"publisher","first-page":"106801","DOI":"10.1016\/j.intimp.2020.106801","volume":"87","author":"X Zhu","year":"2020","unstructured":"Zhu X, Yao Y, Yang J et al (2020) COX-2-PGE2 signaling pathway contributes to hippocampal neuronal injury and cognitive impairment in PTZ-kindled epilepsy mice. Int Immunopharmacol 87:106801. https:\/\/doi.org\/10.1016\/j.intimp.2020.106801","journal-title":"Int Immunopharmacol"},{"key":"3274_CR68","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/epi.16715","volume":"61","author":"T Singh","year":"2020","unstructured":"Singh T, Joshi S, Williamson JM et al (2020) (2020) Neocortical injury\u2013induced status epilepticus. Epilepsia 61:2811\u20132824. https:\/\/doi.org\/10.1111\/epi.16715","journal-title":"Epilepsia"},{"key":"3274_CR69","doi-asserted-by":"publisher","first-page":"106426","DOI":"10.1016\/j.yebeh.2019.07.027","volume":"101","author":"J Williamson","year":"2019","unstructured":"Williamson J, Singh T, Kapur J (2019) Neurobiology of organophosphate-induced seizures. Epilepsy Behav 101:106426. https:\/\/doi.org\/10.1016\/j.yebeh.2019.07.027","journal-title":"Epilepsy Behav"},{"key":"3274_CR70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bbi.2015.12.019","volume":"53","author":"M Llorens-Martin","year":"2016","unstructured":"Llorens-Martin M, Jurado-Arjona J, Bolos M et al (2016) Forced swimming sabotages the morphological and synaptic maturation of newborn granule neurons and triggers a unique pro-inflammatory milieu in the hippocampus. Brain Behav Immun 53:242\u2013254","journal-title":"Brain Behav Immun"},{"key":"3274_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.10.022","volume":"103","author":"AC Rossetti","year":"2016","unstructured":"Rossetti AC, Papp M, Gruca P et al (2016) Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: restorative effect of pharmacological intervention. Pharmacol Res 103:1\u201312","journal-title":"Pharmacol Res"},{"key":"3274_CR72","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.pnpbp.2010.05.019","volume":"34","author":"L Carboni","year":"2010","unstructured":"Carboni L, Becchi S, Piubelli C et al (2010) Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 34:1037\u20131048","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3274_CR73","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457. https:\/\/doi.org\/10.1016\/j.biopsych.2009.09.033","journal-title":"Biol Psychiatry"},{"key":"3274_CR74","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes M et al (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135:373\u2013387. https:\/\/doi.org\/10.1111\/acps.12698","journal-title":"Acta Psychiatr Scand"},{"key":"3274_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.02.004","volume":"113","author":"R Citraro","year":"2015","unstructured":"Citraro R, Leo A, Marra R et al (2015) Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG\/Rij rats. Brain Res Bull 113:1\u20137. https:\/\/doi.org\/10.1016\/j.brainresbull.2015.02.004","journal-title":"Brain Res Bull"},{"key":"3274_CR76","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pnpbp.2012.09.007","volume":"40","author":"YC Li","year":"2013","unstructured":"Li YC, Shen JD, Li J et al (2013) Chronic treatment with baicalin prevents the chronic mild stress-induced depressive-like behavior: Involving the inhibition of cyclooxygenase-2 in rat brain. Prog Neuro-Psychopharmacol Biol Psychiatry 40:138\u2013143. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.09.007","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3274_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12868-016-0246-y","volume":"17","author":"PG Barbalho","year":"2016","unstructured":"Barbalho PG, Lopes-Cendes I, Maurer-Morelli CV (2016) Indomethacin treatment prior to pentylenetetrazole-induced seizures downregulates the expression of il1b and cox2 and decreases seizure-like behavior in zebrafish larvae. BMC Neurosci 17:1\u20139. https:\/\/doi.org\/10.1186\/s12868-016-0246-y","journal-title":"BMC Neurosci"},{"key":"3274_CR78","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1476-5381.2010.00765.x","volume":"160","author":"J Schlichtiger","year":"2010","unstructured":"Schlichtiger J, Pekcec A, Bartmann H et al (2010) Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy. Br J Pharmacol 160:1062\u20131071. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00765.x","journal-title":"Br J Pharmacol"},{"key":"3274_CR79","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.neuropharm.2009.01.009","volume":"56","author":"G Zibell","year":"2009","unstructured":"Zibell G, Unkruer B, Pekcec A et al (2009) Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Neuropharmacology 56:849\u2013855","journal-title":"Neuropharmacology"},{"key":"3274_CR80","first-page":"440","volume":"18","author":"TT Song","year":"2016","unstructured":"Song TT, Li D, Huang SP et al (2016) Effects of cyclooxygenase-2 selective inhibitor celecoxib on the expression of major vault protein in rats with status epilepticus. Zhongguo Dang Dai Er Ke Za Zhi 18:440\u2013445","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"3274_CR81","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jns.2011.05.047","volume":"308","author":"B Liu","year":"2011","unstructured":"Liu B, Wang T, Wang L et al (2011) Up-regulation of major vault protein in the frontal cortex of patients with intractable frontal lobe epilepsy. J Neurol Sci 308:88\u201393","journal-title":"J Neurol Sci"},{"key":"3274_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0563-1","volume":"13","author":"AK Brooks","year":"2016","unstructured":"Brooks AK, Lawson MA, Smith RA et al (2016) Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus. J Neuroinflammation 13:1\u201316. https:\/\/doi.org\/10.1186\/s12974-016-0563-1","journal-title":"J Neuroinflammation"},{"key":"3274_CR83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuroscience.2016.04.036","volume":"328","author":"ZH Xu","year":"2016","unstructured":"Xu ZH, Wang Y, Tao AF et al (2016) Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice. Neuroscience 328:22\u201329. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.04.036","journal-title":"Neuroscience"},{"key":"3274_CR84","doi-asserted-by":"publisher","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","volume":"17","author":"J Kapur","year":"1997","unstructured":"Kapur J, Macdonald RL (1997) Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 17:7532\u20137540. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-19-07532.1997","journal-title":"J Neurosci"},{"key":"3274_CR85","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/sj.mp.4001644","volume":"10","author":"F Hu","year":"2005","unstructured":"Hu F, Wang X, Pace TWW et al (2005) Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function. Mol Psychiatry 10:426\u2013428. https:\/\/doi.org\/10.1038\/sj.mp.4001644","journal-title":"Mol Psychiatry"},{"key":"3274_CR86","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s13311-012-0110-4","volume":"9","author":"EA Pineda","year":"2012","unstructured":"Pineda EA, Hensler JG, Sankar R et al (2012) Interleukin-1beta Causes Fluoxetine resistance in an animal model of epilepsy-associated depression. Neurotherapeutics 9:477\u2013485. https:\/\/doi.org\/10.1007\/s13311-012-0110-4","journal-title":"Neurotherapeutics"},{"key":"3274_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2016.05.019","volume":"784","author":"T Singh","year":"2016","unstructured":"Singh T, Goel RK (2016) Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression. Eur J Pharmacol 784:111\u2013120. https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.019","journal-title":"Eur J Pharmacol"},{"key":"3274_CR88","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-2094-11-41","volume":"11","author":"W Xie","year":"2014","unstructured":"Xie W, Cai L, Yu Y et al (2014) Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuroinflammation 11:41. https:\/\/doi.org\/10.1186\/1742-2094-11-41","journal-title":"J Neuroinflammation"},{"key":"3274_CR89","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nbd.2009.11.001","volume":"37","author":"AM Mazarati","year":"2010","unstructured":"Mazarati AM, Pineda E, Shin D et al (2010) Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis 37:461\u2013467. https:\/\/doi.org\/10.1016\/j.nbd.2009.11.001","journal-title":"Neurobiol Dis"},{"key":"3274_CR90","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/epi4.12317","volume":"2","author":"R Dilena","year":"2019","unstructured":"Dilena R, Mauri E, Aronica E et al (2019) Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection\u2013related epilepsy syndrome. Epilepsia open 2:344\u2013350. https:\/\/doi.org\/10.1002\/epi4.12317","journal-title":"Epilepsia open"},{"key":"3274_CR91","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4172\/2155-9899.1000456","volume":"7","author":"H Jyonouchi","year":"2016","unstructured":"Jyonouchi H, Geng L (2016) Intractable epilepsy (IE) and responses to Anakinra, a human recombinant IL-1 receptor antagonist (IL-1Ra): case reports. J Clin Cell Immunol 7:456\u2013460. https:\/\/doi.org\/10.4172\/2155-9899.1000456","journal-title":"J Clin Cell Immunol"},{"key":"3274_CR92","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12974-018-1063-2","volume":"15","author":"AD DeSena","year":"2018","unstructured":"DeSena AD, Do T, Schulert GS (2018) Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade. J Neuroinflammation 15:38. https:\/\/doi.org\/10.1186\/s12974-018-1063-2","journal-title":"J Neuroinflammation"},{"key":"3274_CR93","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1523\/JNEUROSCI.0066-09.2009","volume":"29","author":"LH Zeng","year":"2009","unstructured":"Zeng LH, Rensing NR, Wong M (2009) The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29:64\u201372. https:\/\/doi.org\/10.1523\/JNEUROSCI.0066-09.2009","journal-title":"J Neurosci"},{"key":"3274_CR94","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/ana.24147","volume":"2014","author":"G Bar-klein","year":"2014","unstructured":"Bar-klein G, Cacheaux LP, Kamintsky L et al (2014) Losartan prevents acquired epilepsy via TGF-\u03b2 signaling suppression. Ann Neurol 2014:864\u2013875. https:\/\/doi.org\/10.1002\/ana.24147","journal-title":"Ann Neurol"},{"key":"3274_CR95","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1111\/ejn.15016","volume":"52","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zong Y, Ren Z et al (2020) Regulation of indoleamine 2, 3-dioxygenase in hippocampal microglia by NLRP3 inflammasome in lipopolysaccharide-induced depressive-like behaviors. Eur J Neurosci 52:4586\u20134601. https:\/\/doi.org\/10.1111\/ejn.15016","journal-title":"Eur J Neurosci"},{"key":"3274_CR96","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.yebeh.2014.10.002","volume":"41","author":"P Singh","year":"2014","unstructured":"Singh P, Singh D, Goel RK (2014) Ficus religiosa L. figs\u2014a potential herbal adjuvant to phenytoin for improved management of epilepsy and associated behavioral comorbidities. Epilepsy Behav 41:171\u2013178. https:\/\/doi.org\/10.1016\/j.yebeh.2014.10.002","journal-title":"Epilepsy Behav"},{"key":"3274_CR97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pharep.2016.10.001","volume":"69","author":"T Singh","year":"2017","unstructured":"Singh T, Goel RK (2017) Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression. Pharmacol Rep 69:143\u2013149. https:\/\/doi.org\/10.1016\/j.pharep.2016.10.001","journal-title":"Pharmacol Rep"},{"key":"3274_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuint.2016.12.023","volume":"104","author":"T Singh","year":"2017","unstructured":"Singh T, Kaur T, Goel RK (2017) Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. Neurochem Int 104:27\u201333. https:\/\/doi.org\/10.1016\/j.neuint.2016.12.023","journal-title":"Neurochem Int"},{"key":"3274_CR99","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopha.2017.05.085","volume":"92","author":"T Singh","year":"2017","unstructured":"Singh T, Bagga N, Kaur A et al (2017) Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals. Biomed Pharmacother 92:720\u2013725. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.085","journal-title":"Biomed Pharmacother"},{"key":"3274_CR100","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1007\/s11064-017-2325-6","volume":"42","author":"T Singh","year":"2017","unstructured":"Singh T, Kaur T, Goel RK (2017) Ferulic acid supplementation for management of depression in epilepsy. Neurochem Res 42:2940\u20132948. https:\/\/doi.org\/10.1007\/s11064-017-2325-6","journal-title":"Neurochem Res"},{"key":"3274_CR101","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yebeh.2016.10.007","volume":"66","author":"T Singh","year":"2017","unstructured":"Singh T, Goel RK (2017) Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers? Epilepsy Behav 66:93\u201399. https:\/\/doi.org\/10.1016\/j.yebeh.2016.10.007","journal-title":"Epilepsy Behav"},{"key":"3274_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2014.00012","volume":"8","author":"BM Campbell","year":"2014","unstructured":"Campbell BM, Charych E, Lee AW et al (2014) Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci 8:1\u201322. https:\/\/doi.org\/10.3389\/fnins.2014.00012","journal-title":"Front Neurosci"},{"key":"3274_CR103","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F et al (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12:64\u201382. https:\/\/doi.org\/10.1038\/nrd3793","journal-title":"Nat Rev Drug Discov"},{"key":"3274_CR104","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF01262727","volume":"42","author":"IP Lapin","year":"1978","unstructured":"Lapin IP (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42:37\u201343. https:\/\/doi.org\/10.1007\/BF01262727","journal-title":"J Neural Transm"},{"key":"3274_CR105","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/BF00966592","volume":"16","author":"C Rios","year":"1991","unstructured":"Rios C, Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 16:1139\u20131143. https:\/\/doi.org\/10.1007\/BF00966592","journal-title":"Neurochem Res"},{"key":"3274_CR106","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1097\/00001756-200108280-00020","volume":"12","author":"A Santamar\u00eda","year":"2001","unstructured":"Santamar\u00eda A, Jim\u00e9nez-Capdeville ME, Camacho A et al (2001) In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. NeuroReport 12:2693\u20132696. https:\/\/doi.org\/10.1097\/00001756-200108280-00020","journal-title":"NeuroReport"},{"key":"3274_CR107","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0006-8993(99)02474-9","volume":"858","author":"E Rodr\u00edguez-Mart\u00ednez","year":"2000","unstructured":"Rodr\u00edguez-Mart\u00ednez E, Camacho A, Maldonado PD et al (2000) Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res 858:436\u2013439. https:\/\/doi.org\/10.1016\/S0006-8993(99)02474-9","journal-title":"Brain Res"},{"key":"3274_CR108","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0014-4886(89)90149-0","volume":"106","author":"A Vezzani","year":"1989","unstructured":"Vezzani A, Stasi MA, Wu HQ et al (1989) Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood-brain barrier permeability. Exp Neurol 106:90\u201398. https:\/\/doi.org\/10.1016\/0014-4886(89)90149-0","journal-title":"Exp Neurol"},{"key":"3274_CR109","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0006-8993(93)91612-V","volume":"619","author":"K Nakano","year":"1993","unstructured":"Nakano K, Takahashi S, Mizobuchi M et al (1993) High levels of quinolinic acid in brain of epilepsy-prone E1 mice. Brain Res 619:195\u2013198. https:\/\/doi.org\/10.1016\/0006-8993(93)91612-V","journal-title":"Brain Res"},{"key":"3274_CR110","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/exnr.1994.1015","volume":"125","author":"CL Eastman","year":"1994","unstructured":"Eastman CL, Urba\u0144ska E, L\u00f6ve A et al (1994) Increased brain quinolinic acid production in mice infected with a hamster neurotropic measles virus. Exp Neurol 125:119\u2013124","journal-title":"Exp Neurol"},{"key":"3274_CR111","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609\u2013620. https:\/\/doi.org\/10.1038\/nrd870","journal-title":"Nat Rev Drug Discov"},{"key":"3274_CR112","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.eplepsyres.2011.02.003","volume":"94","author":"S Liimatainen","year":"2011","unstructured":"Liimatainen S, Lehtim\u00e4ki K, Raitala A et al (2011) Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy. Epilepsy Res 94:206\u2013212. https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.02.003","journal-title":"Epilepsy Res"},{"key":"3274_CR113","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2147\/NDT.S17573","volume":"7","author":"DM Christmas","year":"2011","unstructured":"Christmas DM, Potokar JP, Davies SJ (2011) A biological pathway linking inflammation and depression: activation of indoleamine 2, 3-dioxygenase. Neuropsychiatr Dis Treat 7:431. https:\/\/doi.org\/10.2147\/NDT.S17573","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3274_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15222","author":"WJ Suento","year":"2020","unstructured":"Suento WJ, Kunisawa K, Wulaer B et al (2020) Prefrontal cortex miR-874-3p prevents lipopolysaccharide-induced depression-like behavior through inhibition of indoleamine 2, 3-dioxygenase 1 expression in mice. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.15222","journal-title":"J Neurochem"},{"key":"3274_CR115","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1177\/0269881115599386","volume":"29","author":"N Hazari","year":"2015","unstructured":"Hazari N, Bhad R (2015) Kynurenine pathway (KP) inhibitors: Novel agents for the management of depression. J Psychopharmacol 29:1133\u20131134. https:\/\/doi.org\/10.1177\/0269881115599386","journal-title":"J Psychopharmacol"},{"key":"3274_CR116","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.yebeh.2012.03.035","volume":"24","author":"DD Wang","year":"2012","unstructured":"Wang DD, Englot DJ, Garcia PA et al (2012) Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo. Epilepsy Behav 24:314\u2013318. https:\/\/doi.org\/10.1016\/j.yebeh.2012.03.035","journal-title":"Epilepsy Behav"},{"key":"3274_CR117","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","volume":"287","author":"N Wang","year":"2015","unstructured":"Wang N, Mi X, Gao B et al (2015) Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neuroscience 287:144\u2013156. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.12.021","journal-title":"Neuroscience"},{"key":"3274_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2015.00005","volume":"9","author":"LS Zheng","year":"2015","unstructured":"Zheng LS, Kaneko N, Sawamoto K (2015) Minocycline treatment ameliorates interferon-alpha-induced neurogenic defects and depression-like behaviors in mice. Front Cell Neurosci 9:1\u201310. https:\/\/doi.org\/10.3389\/fncel.2015.00005","journal-title":"Front Cell Neurosci"},{"key":"3274_CR119","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4155\/fmc.14.151","volume":"7","author":"T Jiang","year":"2015","unstructured":"Jiang T, Sun Y, Yin Z et al (2015) Research progress of indoleamine 2,3-dioxygenase inhibitors. Fut Med Chem 7:185\u2013201. https:\/\/doi.org\/10.4155\/fmc.14.151","journal-title":"Fut Med Chem"},{"key":"3274_CR120","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.seizure.2019.05.006","volume":"69","author":"I \u017barnowska","year":"2019","unstructured":"\u017barnowska I, Wr\u00f3bel-Dudzi\u0144ska D, Tulidowicz-Bielak M et al (2019) Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy. Seizure 69:265\u2013272. https:\/\/doi.org\/10.1016\/j.seizure.2019.05.006","journal-title":"Seizure"},{"key":"3274_CR121","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.brainresbull.2008.10.010","volume":"78","author":"P Maciejak","year":"2009","unstructured":"Maciejak P, Szyndler J, Turzy\u0144ska D et al (2009) Time course of changes in the concentration of kynurenic acid in the brain of pentylenetetrazol-kindled rats. Brain Res Bull 78:299\u2013305. https:\/\/doi.org\/10.1016\/j.brainresbull.2008.10.010","journal-title":"Brain Res Bull"},{"key":"3274_CR122","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/epi.14675","volume":"60","author":"MB Juda","year":"2019","unstructured":"Juda MB, Brooks AK, Towers AE et al (2019) Indoleamine 2,3-dioxygenase 1 deletion promotes Theiler\u2019s virus\u2013induced seizures in C57BL\/6J mice. Epilepsia 60:626\u2013635. https:\/\/doi.org\/10.1111\/epi.14675","journal-title":"Epilepsia"},{"key":"3274_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2015.00116","volume":"6","author":"JM Parrott","year":"2015","unstructured":"Parrott JM, O\u2019Connor JC (2015) Kynurenine 3-monooxygenase: an influential mediator of neuropathology. Front Psychiatry 6:1\u201317. https:\/\/doi.org\/10.3389\/fpsyt.2015.00116","journal-title":"Front Psychiatry"},{"key":"3274_CR124","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137\u2013162. https:\/\/doi.org\/10.1038\/npp.2011.205","journal-title":"Neuropsychopharmacology"},{"key":"3274_CR125","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1528-1167.2005.67404.x","volume":"46","author":"HQ Wu","year":"2005","unstructured":"Wu HQ, Rassoulpour A, Goodman JH et al (2005) Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats. Epilepsia 46:1010\u20131016. https:\/\/doi.org\/10.1111\/j.1528-1167.2005.67404.x","journal-title":"Epilepsia"},{"key":"3274_CR126","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1503\/jpn.120228","volume":"38","author":"WL Zhu","year":"2013","unstructured":"Zhu WL, Wang SJ, Liu MM et al (2013) Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats. J Psychiatry Neurosci 38:306\u2013316. https:\/\/doi.org\/10.1503\/jpn.120228","journal-title":"J Psychiatry Neurosci"},{"key":"3274_CR127","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00213-014-3690-3","volume":"232","author":"LB Bin","year":"2015","unstructured":"Bin LB, Luo L, Liu XL et al (2015) 7-Chlorokynurenic acid (7-CTKA) produces rapid antidepressant-like effects: through regulating hippocampal microRNA expressions involved in TrkB-ERK\/Akt signaling pathways in mice exposed to chronic unpredictable mild stress. Psychopharmacology 232:541\u2013550. https:\/\/doi.org\/10.1007\/s00213-014-3690-3","journal-title":"Psychopharmacology"},{"key":"3274_CR128","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1124\/jpet.115.225664","volume":"355","author":"P Zanos","year":"2015","unstructured":"Zanos P, Piantadosi SC, Wu HQ et al (2015) The prodrug 4-chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA\/glycineB-site inhibitionS. J Pharmacol Exp Ther 355:76\u201385. https:\/\/doi.org\/10.1124\/jpet.115.225664","journal-title":"J Pharmacol Exp Ther"},{"key":"3274_CR129","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2011.05.023","volume":"233","author":"SC Danzer","year":"2012","unstructured":"Danzer SC (2012) Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 233:22\u201332. https:\/\/doi.org\/10.1016\/j.expneurol.2011.05.023","journal-title":"Exp Neurol"},{"key":"3274_CR130","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","volume":"287","author":"FH Gage","year":"2000","unstructured":"Gage FH (2000) Mammalian neural stem cells. Science 287:1433\u20131438. https:\/\/doi.org\/10.1126\/science.287.5457.1433","journal-title":"Science"},{"key":"3274_CR131","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.neuron.2012.12.033","volume":"77","author":"M Zhou","year":"2013","unstructured":"Zhou M, Li W, Huang S et al (2013) mTOR inhibition ameliorates cognitive and affective deficits caused by disc1 knockdown in adult-born dentate granule neurons. Neuron 77:647\u2013654. https:\/\/doi.org\/10.1016\/j.neuron.2012.12.033","journal-title":"Neuron"},{"key":"3274_CR132","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/epi.13357","volume":"57","author":"M Raijmakers","year":"2016","unstructured":"Raijmakers M, Clynen E, Smisdom N et al (2016) Experimental febrile seizures increase dendritic complexity of newborn dentate granule cells. Epilepsia 57:717\u2013726. https:\/\/doi.org\/10.1111\/epi.13357","journal-title":"Epilepsia"},{"key":"3274_CR133","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1523\/JNEUROSCI.2728-10.2011","volume":"31","author":"BL Murphy","year":"2011","unstructured":"Murphy BL, Pun RYK, Yin H et al (2011) Heterogeneous integration of adult-generated granule cells into the epileptic brain. J Neurosci 31:105\u2013117. https:\/\/doi.org\/10.1523\/JNEUROSCI.2728-10.2011","journal-title":"J Neurosci"},{"key":"3274_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00063","author":"MJ Korn","year":"2016","unstructured":"Korn MJ, Mandle QJ, Parent JM (2016) Conditional disabled-1 deletion in mice alters hippocampal neurogenesis and reduces seizure threshold. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2016.00063","journal-title":"Front Neurosci"},{"key":"3274_CR135","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1073\/pnas.1015425108","volume":"108","author":"BH Singer","year":"2011","unstructured":"Singer BH, Gamelli AE, Fuller CL et al (2011) Compensatory network changes in the dentate gyrus restore long-term potentiation following ablation of neurogenesis in young-adult mice. Proc Natl Acad Sci U S A 108:5437\u20135442. https:\/\/doi.org\/10.1073\/pnas.1015425108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3274_CR136","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.neuroscience.2011.09.034","volume":"197","author":"VR Santos","year":"2011","unstructured":"Santos VR, de Castro OW, Pun RYK et al (2011) Contributions of mature granule cells to structural plasticity in temporal lobe epilepsy. Neuroscience 197:348\u2013357. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.09.034","journal-title":"Neuroscience"},{"key":"3274_CR137","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.mehy.2011.02.039","volume":"76","author":"M Fang","year":"2011","unstructured":"Fang M, Xi ZQ, Wu Y, Wang XF (2011) A new hypothesis of drug refractory epilepsy: neural network hypothesis. Med Hypotheses 76:871\u2013876. https:\/\/doi.org\/10.1016\/j.mehy.2011.02.039","journal-title":"Med Hypotheses"},{"key":"3274_CR138","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2014.07.038","volume":"277","author":"N Alenina","year":"2015","unstructured":"Alenina N, Klempin F (2015) The role of serotonin in adult hippocampal neurogenesis. Behav Brain Res 277:49\u201357. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.038","journal-title":"Behav Brain Res"},{"key":"3274_CR139","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2011.05.008","volume":"666","author":"K Jaako","year":"2011","unstructured":"Jaako K, Aonurm-Helm A, Kalda A et al (2011) Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus. Eur J Pharmacol 666:61\u201371. https:\/\/doi.org\/10.1016\/j.ejphar.2011.05.008","journal-title":"Eur J Pharmacol"},{"key":"3274_CR140","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brainres.2009.06.089","volume":"1288","author":"K Jaako","year":"2009","unstructured":"Jaako K, Zharkovsky T, Zharkovsky A (2009) Effects of repeated citalopram treatment on kainic acid-induced neurogenesis in adult mouse hippocampus. Brain Res 1288:18\u201328. https:\/\/doi.org\/10.1016\/j.brainres.2009.06.089","journal-title":"Brain Res"},{"key":"3274_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7606","volume":"6","author":"KO Cho","year":"2015","unstructured":"Cho KO, Lybrand ZR, Ito N et al (2015) Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline. Nat Commun 6:1\u201313. https:\/\/doi.org\/10.1038\/ncomms7606","journal-title":"Nat Commun"},{"key":"3274_CR142","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.1523\/JNEUROSCI.0920-19.2019","volume":"39","author":"P Varma","year":"2019","unstructured":"Varma P, Brulet R, Zhang L et al (2019) Targeting seizure-induced neurogenesis in a clinically relevant time period leads to transient but not persistent seizure reduction. J Neurosci 39:7019\u20137028. https:\/\/doi.org\/10.1523\/JNEUROSCI.0920-19.2019","journal-title":"J Neurosci"},{"key":"3274_CR143","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0920-1211(97)00102-2","volume":"30","author":"RM Arida","year":"1998","unstructured":"Arida RM, De Jesus VA, Cavalheiro EA (1998) Effect of physical exercise on kindling development. Epilepsy Res 30:127\u2013132. https:\/\/doi.org\/10.1016\/S0920-1211(97)00102-2","journal-title":"Epilepsy Res"},{"key":"3274_CR144","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/7449","volume":"5","author":"D Young","year":"1999","unstructured":"Young D, Lawlor PA, Leone P et al (1999) Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 5:448\u2013453. https:\/\/doi.org\/10.1038\/7449","journal-title":"Nat Med"},{"key":"3274_CR145","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainres.2016.03.008","volume":"1642","author":"Z Setkowicz","year":"2016","unstructured":"Setkowicz Z, Kosonowska E, Kaczy\u0144ska M et al (2016) Physical training decreases susceptibility to pilocarpine-induced seizures in the injured rat brain. Brain Res 1642:20\u201332. https:\/\/doi.org\/10.1016\/j.brainres.2016.03.008","journal-title":"Brain Res"},{"key":"3274_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep17807","volume":"5","author":"V Mishra","year":"2015","unstructured":"Mishra V, Shuai B, Kodali M et al (2015) Resveratrol treatment after status epilepticus restrains neurodegeneration and abnormal neurogenesis with suppression of oxidative stress and inflammation. Sci Rep 5:1\u201319. https:\/\/doi.org\/10.1038\/srep17807","journal-title":"Sci Rep"},{"key":"3274_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2016.03.015","volume":"280","author":"MS Hester","year":"2016","unstructured":"Hester MS, Hosford BE, Santos VR et al (2016) Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain. Exp Neurol 280:1\u201312. https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.015","journal-title":"Exp Neurol"},{"key":"3274_CR148","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.yebeh.2012.09.040","volume":"26","author":"J Maguire","year":"2013","unstructured":"Maguire J, Salpekar JA (2013) Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy. Epilepsy Behav 26:352\u2013362. https:\/\/doi.org\/10.1016\/j.yebeh.2012.09.040","journal-title":"Epilepsy Behav"},{"key":"3274_CR149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.eplepsyres.2013.10.013","volume":"108","author":"KK O\u2019Toole","year":"2014","unstructured":"O\u2019Toole KK, Hooper A, Wakefield S et al (2014) Seizure-induced disinhibition of the HPA axis increases seizure susceptibility. Epilepsy Res 108:29\u201343. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.10.013","journal-title":"Epilepsy Res"},{"key":"3274_CR150","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.psyneuen.2007.05.011","volume":"32","author":"G Kumar","year":"2007","unstructured":"Kumar G, Couper A, O\u2019Brien TJ et al (2007) The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology 32:834\u2013842. https:\/\/doi.org\/10.1016\/j.psyneuen.2007.05.011","journal-title":"Psychoneuroendocrinology"},{"key":"3274_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0046044","volume":"7","author":"OW Castro","year":"2012","unstructured":"Castro OW, Santos VR, Pun RYK et al (2012) Impact of corticosterone treatment on spontaneous seizure frequency and epileptiform activity in mice with chronic epilepsy. PLoS ONE 7:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0046044","journal-title":"PLoS ONE"},{"key":"3274_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0197955","volume":"13","author":"AC Wulsin","year":"2018","unstructured":"Wulsin AC, Franco-Villanueva A, Romancheck C et al (2018) Functional disruption of stress modulatory circuits in a model of temporal lobe epilepsy. PLoS ONE 13:1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0197955","journal-title":"PLoS ONE"},{"key":"3274_CR153","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1528-1167.2008.01902.x","volume":"50","author":"M Jo\u00ebls","year":"2009","unstructured":"Jo\u00ebls M (2009) Stress, the hippocampus, and epilepsy. Epilepsia 50:586\u2013597. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01902.x","journal-title":"Epilepsia"},{"key":"3274_CR154","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.eplepsyres.2014.10.003","volume":"109","author":"G MacKenzie","year":"2015","unstructured":"MacKenzie G, Maguire J (2015) Chronic stress shifts the GABA reversal potential in the hippocampus and increases seizure susceptibility. Epilepsy Res 109:13\u201327. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.10.003","journal-title":"Epilepsy Res"},{"key":"3274_CR155","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137\u2013151. https:\/\/doi.org\/10.1038\/nrn1846","journal-title":"Nat Rev Neurosci"},{"key":"3274_CR156","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1152\/jn.00821.2006","volume":"97","author":"P Chameau","year":"2007","unstructured":"Chameau P, Qin Y, Spijker S et al (2007) Glucocorticoids specifically enhance L-type calcium current amplitude and affect calcium channel subunit expression in the mouse hippocampus. J Neurophysiol 97:5\u201314. https:\/\/doi.org\/10.1152\/jn.00821.2006","journal-title":"J Neurophysiol"},{"key":"3274_CR157","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1528-1157.1987.tb03689.x","volume":"28","author":"A Culebras","year":"1987","unstructured":"Culebras A, Miller M, Bertram L et al (1987) Differential response of growth hormone, cortisol, and prolactin to seizures and to stress. Epilepsia 28:564\u2013570. https:\/\/doi.org\/10.1111\/j.1528-1157.1987.tb03689.x","journal-title":"Epilepsia"},{"key":"3274_CR158","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.psy.41.2.152","volume":"41","author":"Z Tunca","year":"2000","unstructured":"Tunca Z, Ergene \u00dc, Fidaner H et al (2000) Reevaluation of serum cortisol in conversion disorder with seizure (pseudoseizure). Psychosomatics 41:152\u2013153. https:\/\/doi.org\/10.1176\/appi.psy.41.2.152","journal-title":"Psychosomatics"},{"key":"3274_CR159","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jnnp.43.2.163","volume":"43","author":"RJ Abbott","year":"1980","unstructured":"Abbott RJ, Browning MCK, Davidson DLW (1980) Serum prolactin and cortisol concentrations after grand mal seizures. J Neurol Neurosurg Psychiatry 43:163\u2013167. https:\/\/doi.org\/10.1136\/jnnp.43.2.163","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3274_CR160","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ana.410180115","volume":"18","author":"PB Pritchard","year":"1985","unstructured":"Pritchard PB, Wannamaker BB, Sagel J (1985) Daniel CM (1985) Serum prolactin and cortisol levels in evaluation of pseudoepileptic seizures. Ann Neurol 18:87\u201389. https:\/\/doi.org\/10.1002\/ana.410180115","journal-title":"Ann Neurol"},{"key":"3274_CR161","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.0013-9580.2005.59704.x","volume":"46","author":"CA Galimberti","year":"2005","unstructured":"Galimberti CA, Magri F, Copello F et al (2005) Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment. Epilepsia 46:517\u2013523. https:\/\/doi.org\/10.1111\/j.0013-9580.2005.59704.x","journal-title":"Epilepsia"},{"key":"3274_CR162","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/edrv-12-2-118","volume":"12","author":"L Jacobson","year":"1991","unstructured":"Jacobson L, Sapolsky R (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12:118\u2013134. https:\/\/doi.org\/10.1210\/edrv-12-2-118","journal-title":"Endocr Rev"},{"key":"3274_CR163","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/FBP.0b013e328340d630","volume":"21","author":"C Belzung","year":"2010","unstructured":"Belzung C, Villemeur DEB (2010) The design of new antidepressants: Can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature. Behav Pharmacol 21:677\u2013689. https:\/\/doi.org\/10.1097\/FBP.0b013e328340d630","journal-title":"Behav Pharmacol"},{"key":"3274_CR164","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0166-2236(96)10069-2","volume":"20","author":"JP Herman","year":"1997","unstructured":"Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78\u201384. https:\/\/doi.org\/10.1016\/S0166-2236(96)10069-2","journal-title":"Trends Neurosci"},{"key":"3274_CR165","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","volume":"168","author":"SA Johnson","year":"2006","unstructured":"Johnson SA, Fournier NM, Kalynchuk LE (2006) Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res 168:280\u2013288. https:\/\/doi.org\/10.1016\/j.bbr.2005.11.019","journal-title":"Behav Brain Res"},{"key":"3274_CR166","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/0028-3908(94)90147-3","volume":"33","author":"AJ Roberts","year":"1994","unstructured":"Roberts AJ, Keith LD (1994) Sensitivity of the circadian rhythm of kainic acid-induced convulsion susceptibility to manipulations of corticosterone levels and mineralocorticoid receptor binding. Neuropharmacology 33:1087\u20131093. https:\/\/doi.org\/10.1016\/0028-3908(94)90147-3","journal-title":"Neuropharmacology"},{"key":"3274_CR167","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(93)90497-B","volume":"629","author":"MA Kling","year":"1993","unstructured":"Kling MA, Smith MA, Glowa JR et al (1993) Facilitation of cocaine kindling by glucocorticoids in rats. Brain Res 629:163\u2013166. https:\/\/doi.org\/10.1016\/0006-8993(93)90497-B","journal-title":"Brain Res"},{"key":"3274_CR168","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1460-9568.1999.00495.x","volume":"11","author":"H Karst","year":"1999","unstructured":"Karst H (1999) Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state. Eur J Neurosci 11:889\u2013898. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00495.x","journal-title":"Eur J Neurosci"},{"key":"3274_CR169","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.nbd.2009.02.018","volume":"34","author":"AM Mazarati","year":"2009","unstructured":"Mazarati AM, Shin D, Kwon YS et al (2009) Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol Dis 34:457\u2013461. https:\/\/doi.org\/10.1016\/j.nbd.2009.02.018","journal-title":"Neurobiol Dis"},{"key":"3274_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/neuro.08.024.2009","volume":"3","author":"AS Koe","year":"2009","unstructured":"Koe AS, Jones NC, Salzberg MR (2009) Early life stress as an influence on limbic epilepsy: an hypothesis whose time has come? Front Behav Neurosci 3:1\u201316. https:\/\/doi.org\/10.3389\/neuro.08.024.2009","journal-title":"Front Behav Neurosci"},{"key":"3274_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2014.00008","volume":"7","author":"LT Huang","year":"2014","unstructured":"Huang LT (2014) Early-life stress impacts the developing hippocampus and primes seizure occurrence: cellular, molecular, and epigenetic mechanisms. Front Mol Neurosci 7:1\u201315. https:\/\/doi.org\/10.3389\/fnmol.2014.00008","journal-title":"Front Mol Neurosci"},{"key":"3274_CR172","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/npp.2011.220","volume":"36","author":"ND Hanson","year":"2011","unstructured":"Hanson ND, Owens MJ, Nemeroff CB (2011) Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 36:2589\u20132602. https:\/\/doi.org\/10.1038\/npp.2011.220","journal-title":"Neuropsychopharmacology"},{"key":"3274_CR173","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuropharm.2011.09.003","volume":"62","author":"D Petrik","year":"2012","unstructured":"Petrik D, Lagace DC, Eisch AJ (2012) The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology 62:21\u201334. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.09.003","journal-title":"Neuropharmacology"},{"key":"3274_CR174","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0361-9230(98)00111-7","volume":"47","author":"TA Slotkin","year":"1998","unstructured":"Slotkin TA, Seidler FJ, Ritchie JC (1998) Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. Brain Res Bull 47:345\u2013348. https:\/\/doi.org\/10.1016\/S0361-9230(98)00111-7","journal-title":"Brain Res Bull"},{"key":"3274_CR175","doi-asserted-by":"publisher","first-page":"13456","DOI":"10.1073\/pnas.96.23.13456","volume":"96","author":"YJG Karten","year":"1999","unstructured":"Karten YJG, Nair SM, Van Essen L et al (1999) Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc Natl Acad Sci USA 96:13456\u201313461. https:\/\/doi.org\/10.1073\/pnas.96.23.13456","journal-title":"Proc Natl Acad Sci USA"},{"key":"3274_CR176","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.npp.1300016","volume":"28","author":"MM Leitch","year":"2003","unstructured":"Leitch MM, Ingram CD, Young AH et al (2003) Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: Relevance for depression. Neuropsychopharmacology 28:119\u2013125. https:\/\/doi.org\/10.1038\/sj.npp.1300016","journal-title":"Neuropsychopharmacology"},{"key":"3274_CR177","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1474-4422(12)70201-6","volume":"11","author":"AM Kanner","year":"2012","unstructured":"Kanner AM (2012) Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? Lancet Neurol 11:1093\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(12)70201-6","journal-title":"Lancet Neurol"},{"key":"3274_CR178","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.yebeh.2017.10.025","volume":"78","author":"A Hooper","year":"2018","unstructured":"Hooper A, Paracha R, Maguire J (2018) Seizure-induced activation of the HPA axis increases seizure frequency and comorbid depression-like behaviors. Epilepsy Behav 78:124\u2013133. https:\/\/doi.org\/10.1016\/j.yebeh.2017.10.025","journal-title":"Epilepsy Behav"},{"key":"3274_CR179","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bcp.2015.03.011","volume":"95","author":"E Dale","year":"2015","unstructured":"Dale E, Bang-Andersen B, S\u00e1nchez C (2015) Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochem Pharmacol 95:81\u201397. https:\/\/doi.org\/10.1016\/j.bcp.2015.03.011","journal-title":"Biochem Pharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03274-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:21:32Z","timestamp":1619673692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03274-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":179,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3274"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03274-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}